Viralgen Partners with Elaaj Bio to Advance Gene Therapy for CDKL5 Deficiency Disorder
Viralgen partners with Elaaj Bio to advance an AAV-based gene therapy program for CDKL5 Deficiency Disorder, leveraging specialised manufacturing expertise.
Biotech Partnerships | 06/05/2026 | By News Bureau
CDR-Life Hits First Milestone in Boehringer Ingelheim Autoimmune Deal
CDR-Life has achieved its first milestone in its partnership with Boehringer Ingelheim, advancing an antibody-based programme targeting autoimmune diseases.
Biotech Partnerships | 24/03/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy